Cyteir Therapeutics
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Cyteir Therapeutics's balance sheet done over the years? Its assets were worth $153,232,000 last year, which is less than in the previous period. 5% of Cyteir Therapeutics’s total assets is currently financed by debt. Its liabilities reached the amount of $6,946,000, which means an decrease by -14% compared compared to last year.

Debt to Assets

Cyteir Therapeutics, Inc. (NASDAQ:CYT): Debt to assets
2019 31369000 59.70M 190.33%
2020 13735000 61.76M 449.7%
2021 195388000 8.09M 4.14%
2022 153232000 6.94M 4.53%

CYT Balance Sheet (2019 – 2022)

2022 2021 2020 2019
Assets
Current assets:
Cash and cash equivalents
147.12M189.72M10.93M29.01M
Short term investments
0000
Net receivables
038K63K164K
Inventory
0-38K-63K1.26M
Other current assets
2.08M3.35M1.19M1K
Total current assets
149.20M193.07M12.13M30.43M
Non-current assets:
Property, Plant and Equipment
1.69M2.05M1.28M788K
Goodwill
0000
Intangible assets
0000
Long term investments
0256K256K144K
Other non-current assets
2.32M061K0
Total non-current assets
4.02M2.31M1.60M932K
Total assets
153.23M195.38M13.73M31.36M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
0000
Short term debt
889K000
Total current liabilities
5.31M7.51M3.13M1.97M
Non-current liabilities:
Long term debt
0000
Deferred tax
0000
Other non-current liabilities
1.63M585K58.62M57.73M
Total non-current liabilities
1.63M585K58.62M57.73M
Total liabilities
6.94M8.09M61.76M59.70M
Data sourceData source